Displaying items 13-15 of 15 » View ktuu.com items only< Previous 1 2
Los Angeles TimesThe diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
Staff WriterThe arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...
Los Angeles TimesFaced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
Jun 29, 2010 |Story| Los Angeles Times
Jun 30, 2010 |Story| Health Portal
Jul 15, 2010 |Story| Los Angeles Times
Original site for Actos (drug) topic gallery.